Tari Leslie
CHIEF SCIENTIFIC OFFICER at CDTX
- Sold, on record
- $121k
- Dollars the filings state
- Form 4 sales
- 8
- Latest Mar 11, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CDTXCidara Therapeutics, Inc.CHIEF SCIENTIFIC OFFICER
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CDTXPlan not statedJan 5, 2022 2022
Sold 1,252 shares at $1.25 ($2k)
Tari Leslie, Chief Scientific Officer
Sold 0.8% of holdings ($196k position)155,400 shares leftFirst sale on recordFiling
- 2 Form 4 sale CDTXPlan not statedSep 12, 2022 +250 days
Sold 18,159 shares at $0.68 ($12k)
Tari Leslie, CHIEF SCIENTIFIC OFFICER
Sold 8.6% of holdings ($144k position)193,741 shares leftFiling
- 3 Form 4 sale CDTXUnusualJan 12, 2023 +122 days
Sold 11,814 shares at $1.20 ($14k)
Tari Leslie, CHIEF SCIENTIFIC OFFICER
Sold 88.8% of holdings ($16k position)1,484 shares leftFiling
- 4 Form 4 sale CDTXPlan not statedMar 13, 2023 +60 days
Sold 7,562 shares at $1.53 ($12k)
Tari Leslie, CHIEF SCIENTIFIC OFFICER
Sold 3.8% of holdings ($303k position)190,179 shares left0.6x usual sizeFiling
- 5 Form 4 sale CDTXNo planSep 11, 2023 +182 days
Sold 18,469 shares at $0.95 ($18k)
Tari Leslie, CHIEF SCIENTIFIC OFFICER
No 10b5-1 planSold 6.3% of holdings ($279k position)275,710 shares left1.9x usual sizeFiling
- 6 Form 4 sale CDTXNo planMar 11, 2024 +182 days
Sold 21,029 shares at $0.67 ($14k)
Tari Leslie, CHIEF SCIENTIFIC OFFICER
No 10b5-1 planSold 7.5% of holdings ($187k position)258,681 shares left1.4x usual sizeFiling
- 7 Form 4 sale CDTXNo planSep 11, 2024 +184 days
Sold 909 shares at $11.64 ($11k)
Tari Leslie, CHIEF SCIENTIFIC OFFICER
No 10b5-1 planSold 4.9% of holdings ($218k position)17,788 shares left0.1x usual sizeFiling
- 8 Form 4 sale CDTXNo planMar 11, 2025 +181 days
Sold 1,773 shares at $21.96 ($39k)
Tari Leslie, CHIEF SCIENTIFIC OFFICER
No 10b5-1 planSold 9.9% of holdings ($395k position)16,215 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | Mar 13, 2025 | CDTX | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 1,773 | $39k | 9.9% | No plan | SEC |
| Sep 11, 2024 | Sep 13, 2024 | CDTX | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 909 | $11k | 4.9% | No plan | SEC |
| Mar 11, 2024 | Mar 12, 2024 | CDTX | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 21,029 | $14k | 7.5% | No plan | SEC |
| Sep 11, 2023 | Sep 13, 2023 | CDTX | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 18,469 | $18k | 6.3% | No plan | SEC |
| Mar 13, 2023 | Mar 13, 2023 | CDTX | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 7,562 | $12k | 3.8% | Plan not stated | SEC |
| Jan 12, 2023 | Jan 27, 2023 | CDTX | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 11,814 | $14k | 88.8% | Unusual | SEC |
| Sep 12, 2022 | Sep 13, 2022 | CDTX | CHIEF SCIENTIFIC OFFICER | Form 4 sale | 18,159 | $12k | 8.6% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 7, 2022 | CDTX | Chief Scientific Officer | Form 4 sale | 1,252 | $2k | 0.8% | Plan not stated | SEC |